ASGCT News

Read the ASGCT-Citeline 2024 Q4 Landscape Analysis Field Report

Read the 2024 Q4 Landscape Report | January 27, 2025

While the field has maintained 6-7% growth in the therapeutic pipeline for three years, we’re recording remarkable diversification of therapeutic indications.

ASGCT News

Read Full Story

Interius CEO To Present on in vivo CAR-T at ASGCT Cancer Conference

Register for Advancing Gene and Cell Therapies for Cancer | August 09, 2024

Learn about a first-in-human in vivo CAR T-cell therapy during our inaugural cancer conference this fall.

ASGCT News

Read Full Story

Dr. Terence Flotte Calls for CGT Investment and Collaboration During Congressional Testimony

Read Dr. Flotte's testimony + watch the hearing | February 29, 2024

Read Dr. Flotte's full testimony and watch a recording of the hearing.

ASGCT News  |  Policy & Advocacy

Read Full Story

Mohamed Abou-el-Enein Appointed Editor of Molecular Therapy Methods and Clinical Development

Dr. Abou-el-Enein began five-year term Jan. 1. | January 04, 2024

The former associate editor-in-chief of MTMCD began his five-year term on Jan. 1.

ASGCT News  |  Molecular Therapy

Read Full Story

For Members, ASGCT Has More Programming, Research Funding, and Opportunities Than Ever

Join the largest CGT community | October 03, 2023

If you're not a member yet, join today to get the remainder of 2023 for free.

ASGCT News

Read Full Story

Drew Weissman & Katalin Karikó to Co-Receive 2023 Nobel Prize for Discoveries in mRNA Technology

October 02, 2023

Their findings, which led to the development of the COVID-19 vaccines, changed our understanding of how mRNA interacts with the immune system.

ASGCT News  |  Awards

Read Full Story

Congratulations to Awardees of the ASGCT & Pfizer Medical Education Grants!

August 15, 2023

ASGCT and Pfizer grant supports independent medical education for rare disease cell and gene therapies.

ASGCT News

Read Full Story

ASGCT Statement of Support for the Asian, Asian-American and Pacific Islander Communities

ASGCT Board of Directors | April 27, 2021

Viruses do not originate from, nor are they spread by, specific racial or ethnic groups. As a scientific organization, we are committed to combating this fear and racism through our education and advocacy efforts.

ASGCT News

Read Full Story

Gene, Cell, & RNA Therapy Landscape: Q1 2021

David M. Barrett, J.D., M.S. | April 15, 2021

The first of a new, quarterly publication from ASGCT, the Gene, Cell, & RNA Therapy Landscape report is the only field-wide report covering the therapeutics pipeline, clinical targets, developer progress, and more.

ASGCT News  |  Funding

Read Full Story

New Diversity and Inclusion Awards Aim to Promote Equity in Gene and Cell Therapy Research

David Barrett, J.D., M.S. | February 26, 2021

The application period for three new funding opportunities will open in June.

ASGCT News

Read Full Story

Second mRNA Vaccine for COVID-19 Approved in the U.S.

Stephen J. Russell, M.D., Ph.D. | December 18, 2020

ASGCT President Stephen J. Russell, M.D., Ph.D. reacts to today's FDA approval of the second COVID-19 vaccine authorized for use in the U.S.

ASGCT News  |  President's Message

Read Full Story

Approved mRNA Vaccine for COVID-19 is a Milestone for Gene and Cell Therapy

Stephen J. Russell, M.D., Ph.D. | December 11, 2020

ASGCT President Stephen J. Russell, M.D., Ph.D. reacts to today's FDA approval of the first COVID-19 vaccine authorized for use in the U.S.

ASGCT News  |  President's Message

Read Full Story

Exploring Gene and Cell Therapies for Prostate Cancer

Eoghan J. Mulholland, Ph.D. | November 19, 2020

To recognize International Men's Day, Dr. Eoghan Mulholland describes how gene and cell therapies could eventually lead to the treatment and prevention of prostate cancer.

ASGCT News

Read Full Story

NHLBI-Funded Programs Provide Low-Cost Services to Gene Therapy Researchers

Edith Pfister, Ph.D. | November 11, 2020

The NGVB is one of several NHLBI-supported programs that provide low- to no-cost resources enabling translation of gene therapy research into clinical products.

ASGCT News

Read Full Story

Drs. Mendell and Dunbar Reflect on NAM Election

ASGCT Staff | November 02, 2020

Jerry Mendell, M.D., and Cindy Dunbar, M.D., answer our questions about their election last month to the National Academy of Medicine.

ASGCT News

Read Full Story